Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Buys 74,286 Shares of Company Stock

Key Points

• L1 Capital increased its Anteris Technologies Global stake by purchasing 74,286 shares at $7.72 each, and then acquiring another 322,940 shares at $7.60. Its holdings rose to 4.88 million shares.
• AVR shares fell 2.1% to $7.61, while the company reported a quarterly loss of $0.30 per share and revenue of $1.01 million, both worse than analyst expectations.
• Analyst sentiment remains a “Moderate Buy,” with a consensus price target of $16.00, although ratings range from Cantor Fitzgerald’s $15.00 target and “overweight” view to Weiss Ratings’ “sell” rating.

Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) major shareholder L1 Capital Pty Ltd purchased 74,286 shares of Anteris Technologies Global stock in a transaction that occurred on Wednesday, September 30th. The stock was acquired at an average cost of $7.72 per share, with a total value of $573,487.92. Following the transaction, the insider owned 4,877,827 shares in the company, valued at $37,656,824.44. This trade represents a 1.55% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Thursday, October 1st, L1 Capital Pty Ltd acquired 322,940 shares of Anteris Technologies Global stock. The shares were acquired at an average price of $7.60 per share, for a total transaction of $2,454,344.00.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.83, for a total transaction of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total transaction of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.10, for a total transaction of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total value of $3,853,113.30.
• On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.15, for a total value of $396,994.65.
• On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.04, for a total value of $1,250,260.20.

Anteris Technologies Global Stock Down 2.1%

NASDAQ AVR traded down $0.16 on Thursday, reaching $7.61. The company had a trading volume of 1,170,680 shares, compared to its average volume of 718,688. The company's fifty day moving average is $8.51 and its 200 day moving average is $7.98. Anteris Technologies Global Corp. has a 52-week low of $3.30 and a 52-week high of $11.06. The stock has a market capitalization of $741.67 million, a P/E ratio of -3.90 and a beta of 1.87.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.09). The firm had revenue of $1.01 million for the quarter, compared to analysts' expectations of $1.50 million. Anteris Technologies Global had a negative return on equity of 77.69% and a negative net margin of 4,619.27%.During the same period in the prior year, the firm earned ($0.58) earnings per share. On average, research analysts expect that Anteris Technologies Global Corp. will post -1.21 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on AVR shares. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Anteris Technologies Global in a research report on Wednesday, August 26th. Cantor Fitzgerald reissued an "overweight" rating and set a $15.00 target price on shares of Anteris Technologies Global in a research report on Friday, August 14th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Anteris Technologies Global presently has an average rating of "Moderate Buy" and a consensus price target of $16.00.

Institutional Investors Weigh In On Anteris Technologies Global

Hedge funds have recently modified their holdings of the stock. Nantahala Capital Management LLC bought a new position in Anteris Technologies Global during the second quarter valued at $33,325,850. One68 Global Capital LLC bought a new stake in shares of Anteris Technologies Global in the second quarter valued at $128,000. Bank of America Corp DE purchased a new position in shares of Anteris Technologies Global during the 2nd quarter valued at $1,907,000. AWM Investment Company Inc. purchased a new position in shares of Anteris Technologies Global during the 2nd quarter valued at $1,133,000. Finally, ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global during the 2nd quarter worth $30,979,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. is a medical device company focused on developing advanced technologies for structural heart disease. Its primary product candidate is the DurAVR transcatheter heart valve, designed to treat aortic valve stenosis through a minimally invasive transcatheter aortic valve replacement procedure.

The DurAVR valve is based on Anteris' ADAPT tissue-engineering technology and is manufactured as a single-piece valve intended to replicate the performance and natural hemodynamics of a healthy human aortic valve.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.